Analyst
BMO Capital Markets
Equibles does not estimate personal net worth.
Evan Seegerman is recorded as Analyst at BMO Capital Markets. Evan Seegerman has spoken on 2 earnings calls across 2 companies, most recently for AMGEN-T on November 3, 2026. Those appearances were for AMGEN-T and Amgen Inc (AMGN). The companies whose calls Evan Seegerman spoke on are classified in the Healthcare sector.
“I think, Jay, when we met in that small group meeting back in September, you suggested that although Maritide is administered monthly or even less frequently, the side effect duration is comparable in length to what you get with weekly anchortons.”
“I think, Jay, when we met in that small group meeting back in September, you suggested that although Maritide is administered monthly or even less frequently, the side effect duration is comparable in length to what you get with weekly anchortons.”
BMO Capital Markets
Analyst
Transcript header (unverified)
AMGN
Drug Manufacturers - General · Healthcare
AMGEN-T
Amgen Q3 2026 Earnings Conference Call
AMGEN-T
